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ABCA12 is involved in the transport of ceramides in
skin, but it may play a wider role in lipid metabolism.
We show that, in Abca12-deficient macrophages,
cholesterol efflux failed to respond to activation
with LXR agonists. Abca12 deficiency caused a
reduction in the abundance of Abca1, Abcg1, and
Lxrb. Overexpression of Lxrb reversed the effects.
Mechanistically, Abca12 deficiency did not affect
expression of genes involved in cholesterol meta-
bolism. Instead, a physical association between
Abca1, Abca12, and Lxrb proteins was established.
Abca12 deficiency enhanced interaction between
Abca1 and Lxrb and the degradation of Abca1.
Overexpression of ABCA12 in HeLa-ABCA1 cells
increased the abundance and stability of ABCA1.
Abca12 deficiency caused an accumulation of
cholesterol in macrophages and the formation of
foam cells, impaired reverse cholesterol transport
in vivo, and increased the development of athero-
sclerosis in irradiated Apoe/ mice reconstituted
with Apoe/Abca12/ bone marrow. Thus,
ABCA12 regulates the cellular cholesterol meta-
bolism via an LXRb-dependent posttranscriptional
mechanism.
INTRODUCTION
The dysregulation of cholesterol homeostasis in macrophages is
a pivotal event in the pathogenesis of atherosclerosis, the major
cause of cardiovascular disease. Even small fluctuations of
cellular cholesterol content can cause apoptosis and necrosis.
Macrophages, like all cells, possess a sophisticated regulatory
network controlling cellular cholesterol homeostasis (Maxfield
and Tabas, 2005). These pathways control, on the one hand,
cholesterol biosynthesis and the uptake of cholesterol in low-Celdensity lipoproteins (LDLs) and, on the other, the release of
cellular cholesterol to the extracellular acceptors, such as
apolipoprotein A-I (apoA-I) or high-density lipoprotein (HDL).
Although mechanisms controlling cholesterol delivery have
been investigated in great detail (Brown and Goldstein, 2009),
the mechanisms responsible for regulating cholesterol efflux
are less clear. They are particularly relevant for macrophages,
given that cholesterol efflux in these cells is the major determi-
nant of cholesterol homeostasis.
Three transporters responsible for regulated cholesterol efflux
have been described: ABCA1, which is responsible for the efflux
to lipid-free apoA-I, and ABCG1 and SR-B1, which regulate
efflux to the mature HDL (Yvan-Charvet et al., 2010). However,
numerous studies have indicated that our understanding of the
regulation of cholesterol homeostasis is far from complete (for
review, see Fitzgerald et al., 2010). Recently, we described a
mouse carrying a mutation in another transporter, Abca12
(Smyth et al., 2008), a gene best known for being mutated in a
skin disease, Harlequin ichthyosis (HI). In the skin, ABCA12 plays
a critical role in the transport of ceramides in keratinocytes (Kel-
sell et al., 2005); however, we found that, in fibroblasts lacking
Abca12, cholesterol homeostasis was also perturbed (Smyth
et al., 2008). This prompted us to investigate the broader role
of ABCA12 in cholesterol metabolism and the development of
atherosclerosis.
RESULTS
Abca12 Deficiency Impairs Cholesterol Efflux from
Macrophages
To examine the role of Abca12 in cholesterol efflux, we derived
macrophages from the fetal livers of mouse embryos carrying
the El12 allele of Abca12 (Smyth et al., 2008). ABCA1 is the
sole determinant of specific cholesterol efflux to lipid-free
apoA-I; therefore, apoA-I was used as an acceptor in order to
assess ABCA1-dependent efflux. In cells not activated with
LXR agonist, cholesterol efflux to apoA-I was similar in cells of
all genotypes (Figure 1A). After the activation of Abca1 expres-
sion with the LXR agonist TO-901317, cholesterol efflux was
elevated in Abca12+/+, but not mutant, cells. Consequently,l Metabolism 18, 225–238, August 6, 2013 ª2013 Elsevier Inc. 225
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Figure 1. Cholesterol and Phospholipid Efflux from Abca12-Deficient Cells
(A and B) Cholesterol efflux to apoA-I (A) or HDL (B) from liver macrophages isolated from the Abca12El12 strain.
(C and D) Cholesterol efflux to apoA-I (C) or HDL (D) from liver macrophages isolated from the Abca12Lx12 strain.
(E) Abundance of Abca12 in RAW 264.7 cells after knockdown of Abca12 with siRNA.
(F) Cholesterol efflux to apoA-I from RAW 264.7 cells after knockdown of Abca12 with siRNA.
(G) Phospholipid efflux to apoA-I from liver macrophages isolated from Abca12El12 strain.
(H) Abundance of Abca1, Abcg1, and SR-B1 in RAW 264.7 cells after knockdown of Abca12 with siRNA.
(I) Abca1 and Abcg1 abundance in liver macrophages isolated from the Abca12Lx12 strain.
(legend continued on next page)
Cell Metabolism
ABCA12: A Regulator of Cholesterol Efflux
226 Cell Metabolism 18, 225–238, August 6, 2013 ª2013 Elsevier Inc.
Cell Metabolism
ABCA12: A Regulator of Cholesterol Effluxspecific Abca1-dependent efflux was reduced in Abca12+/El12
cells and almost undetectable inAbca12El12/El12 cells (Figure 1A).
ABCG1 and SR-B1 are the principle mediators of specific
cholesterol efflux to HDL. Expression of ABCG1, but not SR-
B1, is also activated by LXR agonists. We used HDL as an
acceptor and cells activated with LXR agonist to test the effect
of Abca12 deficiency on ABCG1-dependent efflux. In the
absence of agonist, efflux was comparable in cells of all geno-
types. Upon treatment with an LXR agonist, cholesterol efflux
increased in Abca12+/+, but not Abca12El12/El12, cells (Figure 1B).
Similar results were obtained with macrophages derived from
mice carrying the independent Lx12 knockout allele of Abca12
(Yanagi et al., 2010). Fetal macrophages with this mutation ex-
hibited similar defects in cholesterol efflux to apoA-I (Figure 1C)
and HDL (Figure 1D) upon activation with LXR agonist. Nonspe-
cific efflux was unaffected by a loss of Abca12 (Table S1 avail-
able online). These observations were also confirmed in the
RAW 264.7 mouse macrophage cells upon small interfering
RNA (siRNA)-mediated Abca12 knockdown (Figures 1E and
1F). The effects of Abca12 deficiency on phospholipid efflux, a
process also controlled by ABCA1, were similar to the effects
on cholesterol efflux, except that phospholipid efflux was not
impaired in heterozygous cells (Figure 1G).
Given that LXR activation triggers the upregulation of Abca1
and Abcg1 expression, we measured the effect of Abca12
deficiency on levels of these proteins. Abca12 depletion by
siRNAAbca12 resulted in a substantial reduction in the levels of
Abca1 and Abcg1, but not SR-B1, in cells activated with LXR
agonist (Figure 1H). The level of Abca1 after Abca12 silencing
was 66.1%± 4.4%of control (mean ± SEM; n = 7). Similar results
were observed in Abca12Lx12/Lx12 cells (Figure 1I). Interestingly,
in both siRNA-treated RAW 264.7 cells and Abca12Lx12/Lx12
-derived macrophages, the abundance of Lxrb, but not Lxra,
was also reduced (Figures 1J and 1K). The level of Lxrb after
Abca12 silencing was 58.5% ± 5.1% of control (mean ± SEM;
n = 6). Collectively, these data demonstrate that Abca12 defi-
ciency impairs the ability of macrophages to upregulate the
levels of key ATP-binding cassette (ABC) transporters and
cholesterol efflux in response to LXR activation. Both ABCA1
and ABCG1 are known to play a significant role in cellular choles-
terol homeostasis. Whereas the precise role of ABCG1 is still
contentious, the role of ABCA1 is well established. Therefore,
we focused more detailed mechanistic studies on the relation-
ship between ABCA12 and ABCA1.
The Role of Lxrb in Impairment of Cholesterol Efflux in
Abca12-Deficient Cells
Given that LXR primarily mediates its effects via the regulation
of gene transcription, we examined the impact of Abca12
deficiency on the expression of genes involved in lipid meta-
bolism. Using real time RT-PCR, we assessed messenger RNA
(mRNA) levels of Lxra, Lxrb, two LXR target genes (Abca1 and
Abcg1), and several other genes involved in cellular lipid meta-
bolism (Ldlr, Scarb1, Msr1, Abca3, and Hmgcr). As expected,(J) Lxra and Lxrb abundance in RAW 264.7 cells after knockdown of Abca12 wit
(K) Lxra and Lxrb abundance in liver macrophages isolated from Abca12Lx12 stra
Activated cells are cells that have been preincubated with LXR agonist TO-901
represented as mean ± SEM. See also Table S1.
CelAbca12 mRNA was undetectable in Abca12Lx12/Lx12 macro-
phages (Figure 2A). Abca12 deficiency did not have a statistically
significant effect on Abca1 and Abcg1 expression with or without
stimulation by LXR agonists, nor did it have an effect on the
expression of any other genes tested (Figure 2A). Identical out-
comes were observed when gene expression was analyzed in
RAW 264.7 cells with siRNA knockdown of Abca12 (Figure 2B).
Thus, a loss of Abca12 does not impair cholesterol efflux via
transcriptional regulation of the key mediators of cholesterol
homeostasis. This is to be expected, given the functional redun-
dancy between Lxrb and Lxra and the only partial decrease of
Lxrb levels in Abca12-deficient cells.
To control for agonist-specific effects, we treated cells with a
chemically distinct LXR agonist, GW3965 (Joseph et al., 2002),
and observed similar results (Figures 2C and 2D). We also tested
whether the effects of Abca12 deficiency are mediated through
another regulator of ABC transporters, PPAR (Ogata et al.,
2009). Treatment with the PPARa/g agonist RO4509851 did
not reverse the effect of Abca12 deficiency (Figure 2C).
In addition to the LXR-dependent regulatory pathway, murine
cells can activate Abca1 expression and cholesterol efflux in
response to treatment with cAMP (Haidar et al., 2002; Le Goff
et al., 2006). When RAW 264.7 Abca12 knockdown cells were
activated with cAMP, cholesterol efflux was elevated by about
half the level observed in cells transfected with siRNAc (Fig-
ure 2E). cAMPmodulates cholesterol efflux via several transcrip-
tional (Le Goff et al., 2006) and posttranscriptional (Haidar et al.,
2002) mechanisms. Although the abundance of Abca1 protein
was reduced in siRNAAbca12-transfected cells activated with
LXR agonist, the levels of Abca1 mRNA (Figure S1) and protein
(Figure 2F) were unaffected by Abca12 deficiency after activation
with cAMP. We did not observe any effect of Abca12 deficiency
on the cAMP-induced changes in the expression of nine genes
involved in the regulation of lipid metabolism (Figure S1). These
observations suggest that the effects of Abca12 deficiency on
Abca1 abundance are specific for the Lxr-dependent pathway.
However, partial inhibition of cholesterol efflux indicates that
Abca12 deficiency affected Abca1 functionality independently
of its abundance.
To investigate the specific role of LXRb in the impairment
of cholesterol efflux in Abca12-deficient cells, we conducted
‘‘rescue’’ experiments in which RAW 264.7 cells were trans-
fected with siRNAAbca12, Lxrb cDNA, or a combination of the
two. Knockdown of Abca12 rendered cells unresponsive to
treatment with LXR agonist, whereas the transfection of
Abca12-deficient cells with heterologous Lxrb cDNA largely
restored cholesterol efflux and Abca1 abundance (Figures 2G
and 2H). Transfection with Lxrb cDNA alone had no effect
(Figure 2G). These findings confirmed that the effect of
Abca12 deficiency on cholesterol efflux and Abca1 abundance
was at least partially mediated by Lxrb. Altogether, these data
demonstrate that Abca12 regulates Lxrb abundance and
Abca1 protein level and functionality via a posttranscriptional
mechanism.h siRNA.
in.
317 (final concentration, 4 mM). *p < 0.01 (versus WT cells). Pooled data are
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Figure 2. Involvement of Lxrb in the Impairment of Cholesterol Efflux in Abca12-Deficient Cells
(A) Expression of genes involved in lipid metabolism in Abca12 Lx12/Lx12 and Abca12+/+ macrophages with or without activation with LXR agonist TO-901317 as
assessed by real-time RT-PCR. *p < 0.01 (versus nonactivated cells).
(B) Expression of genes involved in lipid metabolism in RAW 264.7 macrophages after knockdown of Abca12. Pooled data are represented as mean ± SEM.
*p < 0.01 (versus nonactivated cells).
(C) Cholesterol efflux to apoA-I fromRAW 264.7 cells after knockdown of Abca12 by siRNA and treatment with LXR agonist TO-901317 (4 mM), GW3965 (1 mM), or
a combination of TO-901317 (4 mM) and PPARa/g agonist RO4509851 (5 mM).
(D) Abundance of Abca1 in RAW 264.7 cells after knockdown of Abca12 by siRNA and activation with LXR ligands.
(E) Cholesterol efflux to apoA-I from RAW 264.7 cells after knockdown of Abca12 and activation by LXR agonist TO-901317 (4 mM) or cAMP (0.3 mM).
(F) Abundance of Abca1 in RAW 264.7 cells after knockdown of Abca12 and activation of Abca1 expression by TO-901317 or cAMP.
(legend continued on next page)
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Abca12
Previous studies have proposed that LXRb can bind directly to
ABCA1, reducing its activity, and LXR agonists interfere with
this interaction, reversing the inhibitory effect of LXRb (Hozoji-
Inada et al., 2011). An additional posttranslational mechanism
that regulates ABCA1 activity and abundance is its relocaliza-
tion: when ABCA1 is displaced from the cell surface, it no longer
supports cholesterol efflux and is rapidly degraded (Neufeld
et al., 2001). Therefore, we investigated the effects of Abca12
deficiency on Abca1 localization and colocalization of Abca1
and Lxrb. The abundance of Abca1 in nonactivated RAW 264.7
cells was low, and there was a degree of colocalization of
Abca1 and Lxrb (colocalization coefficient, 0.56 ± 0.09) (Figures
3A–3C). In cells activated with LXR agonist, the abundance of
Abca1 increased considerably, but the colocalization of Abca1
and Lxrb did not change significantly in comparison to the
nonactivated cells (colocalization coefficient, 0.51 ± 0.04) (Fig-
ures 3D–3F). Remarkably, the colocalization of Abca1 with
Lxrb dramatically increased in cells activated with LXR agonist
and treated with siRNAAbca12 (colocalization coefficient, 0.81 ±
0.04, p < 0.01for cells treated with siRNAAbca12 versus cells
treated with siRNAc) (Figures 3D–3I, lower magnification images
are shown in Figure S2A). The distribution of Abca1 was investi-
gated via the biotinylation of cell-surface Abca1. We observed a
reduction in the abundance of cell-surface Abca1 in Abca12-
deficient cells (Figure 3J). This was also confirmed with the use
of cross-sections of individual cells (Figure 3K) and in confocal
three-dimensional reconstitutions, both of which showed a
reduction of plasmamembrane Abca1 upon Abca12 knockdown
(Movie S1, control, and Movie S2, Abca12 knockdown). The
level of Abca12 in wild-type (WT) RAW 264.7 cells was insuffi-
cient for reliable detection; however, overexpression of heterol-
ogous Abca12 showed clear regions of overlap with Abca1
(Figure 3L).
To investigate whether Abca1stability was affected by Abca12
deficiency, we radioactively labeled newly synthesized Abca1
and performed pulse-chase experiments. Analysis demon-
strated that the degradation rate of Abca1 was increased when
Abca12 was knocked down (Figures 3M and 3N). Furthermore,
the effect was confirmed when cell-surface Abca1 was labeled
with biotin and the abundance of biotinylated Abca1 was
followed; i.e., the rate of Abca1 degradation increased in
Abca12-deficient cells (Figure S2B).
Clearly, Abca12 is able to regulate the stability of Abca1. To
investigate whether a physical interaction between Abca12,
Abca1, and Lxrb may form the basis for these effects, we
employed a proximity ligation assay (PLA) (Baima et al., 2010).
In this assay, the number of fluorescent dots in a given cell is pro-
portional to the number of interaction events between a pair of
heterotypic proteins. When the Abca12 and Abca1 pair was
studied, an abundant interaction was found, and knockdown
of Abca12 significantly reduced this interaction (Figure 3O).
When the Abca1 and Lxrb pair was analyzed, the activation of(G) Cholesterol efflux to apoA-I from RAW 264.7 cells after knockdown of Abca1
*p < 0.01 (versus control cells); #p < 0.001 (versus cells treated with siRNA).
(H) Abundance of Abca1 in RAW 264.7 cells after knockdown of Abca12 and co
See also Figure S1.
Celcells with an LXR agonist increased their interaction, and this
was increased further after Abca12 silencing (Figure 3P and
quantitation in Figure S2C). However, as expected, the abun-
dance of both Abca1 and Lxrb was affected by the addition of
LXR agonist and Abca12 silencing (Figure S2D shows the abun-
dance of Abca12 and Lxrb in this experiment), and, when the
interaction between Abca1 and Lxrb was normalized to the
abundance of the interacting proteins, it was statistically signifi-
cantly reduced after the addition of LXR agonist and elevated
after Abca12 silencing (Figure 3P). We also observed an abun-
dant interaction between Abca12 and Lxrb, which was reduced
when Abca12 was knocked down (Figure 3Q).
Next, we examined HeLa cells stably transfected with GFP-
ABCA1 expressed under the control of a cytomegalovirus
(CMV) promoter (parental HeLa cells do not express homolo-
gous ABCA1) (Mukhamedova et al., 2007). When HeLa-ABCA1
cells were transfected with tGFP-ABCA12, the abundance of
ABCA1 significantly increased (Figure 4A). Overexpression of
ABCA12 in HeLa cells caused a modest elevation of cholesterol
efflux; however, in HeLa-ABCA1 cells, this overexpression did
not increase cholesterol efflux in addition to the efflux caused
by the presence of heterologous ABCA1 (Figure 4B). Then, we
investigated the distribution of ABCA1 and ABCA12 by confocal
microscopy. Consistent with previous reports (Mujawar et al.,
2006; Mukhamedova et al., 2007), most of the ABCA1 in HeLa-
ABCA1 cells localized to the perinuclear area, a smaller propor-
tion being localized at the plasma membrane (Figure 4C).
Transfection with ABCA12 caused the redistribution of ABCA1
to the outer cytoplasm and plasma membrane (Figure 4D),
which was similar to the distribution of ABCA12 (Figure 4E);
there was a significant colocalization of ABCA1 and ABCA12
(Figure 4F).
To investigate whether overexpression of ABCA12 affected
the stability of ABCA1, we used biotin labeling of cell-surface
ABCA1 and found that, although the abundance of total ABCA1
was considerably higher in cells transfected with ABCA12 (Fig-
ure 4G, lane 1), levels of ABCA1 at the cell surface were similar
(Figure 4G, lane 2). This observation explained the lack of effect
of ABCA12 on cholesterol efflux in HeLa-ABCA1 cells. The rate
of degradation of biotinylated ABCA1 was significantly reduced
by ABCA12 (Figures 4G and 4H).
In pull-down experiments, an antibody against ABCA1 copre-
cipitated ABCA12 irrespective of whether or not proteins were
crosslinked prior to immunoprecipitation (Figure 4I). In the recip-
rocal experiment, when ABCA12 was immunoprecipitated,
ABCA1 coimmunoprecipitated with ABCA12 (Figure 4J). When
LXRb was immunoprecipitated from HeLa-ABCA1 cells trans-
fected with ABCA12, both ABCA1 and ABCA12 coimmunopreci-
pitated with LXRb (Figure 4K). Experiments with the PLA assay
confirmed the interaction between ABCA1 and ABCA12 in this
model (Figure 4L). They also revealed that the overexpression
of ABCA12 increased the interaction of ABCA1 and LXRb and
caused a relocalization of this complex to a region surrounding
the nucleus (Figure 4M). Note that cells in this experiment were2 and cotransfection with Lxrb. Pooled data are represented as mean ± SEM.
transfection with Lxrb.
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Figure 3. Mechanism of Modulation of Cholesterol Efflux by Abca12: Studies on RAW 264.7 Cells
(A–I) Confocal microscopy of Abca1 (A, D, andG; green), Lxrb (B, E, and H; red), and amerger of the two (C, F, and I; yellow) in RAW264.7 cells nonactivated (A–C)
or activated with LXR agonist TO-901317 (D–I) with (G–I) or without (A–F) Abca12 knockdown. The scale bar represents 10 mm.
(J) Abundance of total (upper panel) and cell-surface (bottom panel) Abca1 in RAW 264.7 cells with or without Abca12 knockdown.
(legend continued on next page)
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was elevated in cells overexpressing ABCA12.
Altogether, these findings indicate that ABCA12 interacts with
ABCA1 and that a loss of ABCA12 reduces ABCA1 abundance
on the cell surface and enhances its degradation. ABCA12 and
ABCA1 are also likely to interact with LXRb.
Abca12-Deficient Macrophages Accumulate
Cholesterol
In macrophages, deficiencies in cholesterol efflux lead to the
accumulation of cholesterol and the transformation of macro-
phages into foam cells. To investigate the potential contribution
of Abca12 to this process, we assessed the rate of cholesteryl
ester biosynthesis. In Abca12El12/El12 cells, the rate of cholesteryl
ester biosynthesis was 3-fold higher compared to that of
WT counterparts, whereas, under conditions of cholesterol
loading, this difference was 2-fold (Figure 5A). Similar effects
were observed in the Abca12-deficient RAW 264.7 cells (Fig-
ure 5B). Significantly more cells were stained with Oil Red O in
Abca12 knockdown cells in comparison to control cells (Figures
5C and 5D).
Then, we performed a lipidomics analysis in order to
investigate the effect of Abca12 knockdown on lipid accu-
mulation in RAW 264.7 cells. Without cholesterol loading,
Abca12 knockdown resulted in a modest elevation of the
abundance of cholesteryl esters, ceramides, and sphingomye-
lins (Figure 5E). With cholesterol loading, Abca12 deficiency led
to a significant accumulation of cholesterol, cholesteryl esters,
ceramides, sphingomyelins, triglycerides, and phosphatidyl-
choline (Figure 5E). Full lipidomics data are presented in
Table S2.
Altogether, these findings demonstrate that Abca12 defi-
ciency results in the accumulation of lipids in macrophages.
Loss of Abca12 Impairs Reverse Cholesterol Transport
and Promotes Atherosclerosis In Vivo
Next, we assessed the effect of Abca12 deficiency on reverse
cholesterol transport (RCT) in vivo. RAW 264.7 macrophages
transfected with control or Abca12 siRNA were loaded with
cholesterol, labeled, and transplanted into the peritoneal cavity
of mice. The amount of labeled cholesterol exported from mac-
rophages with Abca12 knockdown to plasma and feces was
reduced 2-fold in comparison to control macrophages (Figures
6A and 6C). The amount of cholesterol in the liver was unaffected
(Figure 6B), probably because of the transient nature of this pool.
The ratio of free cholesterol to cholesteryl esters in plasma was(K) Intracellular distribution of Abca1 in RAW 264.7 cells or RAW 264.7 cells after A
stacking the images from sequential scanning of cells shown in the middle panel
along the arrow in the middle panel.
(L) Intracellular distribution of Abca1 (green) and Abca12 (red) in RAW 264.7 cell
(M and N) A pulse-chase experiment of Abca1 degradation in RAW 264.7 cells wit
methionine and cysteine, Abca1 immunoprecipitated, and isolated on SDS-PAGE
these bands (N) are shown. Means ± the range of two experiments are shown.
(O) Proximity ligation assay (PLA) of the Abca1 and Abca12 pair in RAW 264.7 c
(P) PLA of the Abca1 and Lxrb pair in RAW264.7 cells with or without activation wit
normalized to the abundance of Abca1 and Lxrb.
(Q) PLA of the Abca12 and Lxrb pair in RAW 264.7 cells with or without Abca12 k
Experimental Procedures. Means ± SEM of PLA signal per cell are shown. *p < 0
See also Figure S2 and Movies S1 and S2.
Cel0.56 ± 0.27 and 0.57 ± 0.49 (p = 0.96) for control and Abca12
knockdown groups, respectively.
Then, we investigated the effect of Abca12 deficiency on the
development of atherosclerosis in the Apoe/ mice. Given
that Abca12El12/El12 mice are not viable (Smyth et al., 2008), we
used a bone marrow chimera model, transplanting fetal liver
cells (FLCs) harvested from Apoe/ Abca12+/+ or Apoe/
Abca12El12/El12 embryos into Apoe/ mice in which endoge-
nous hematopoiesis had been ablated by irradiation. Bone
marrow chimerism was confirmed by flow cytometric analysis
of peripheral blood leukocytes 8 weeks posttransplantation,
and mice exhibiting >90% donor engraftment commenced a
high-fat diet. After 16 weeks of a high-fat diet, mice transplanted
with Apoe/ Abca12El12/El12 FLCs exhibited double the number
of the plaques in comparison to Abca12+/+ counterparts (Figures
6D and 6H; p < 0.002). The biggest effect was observed in the
aortic arch, the area most susceptible to the development of
atherosclerosis, (Figures 6E and 6H). There was a trend toward
increased atherosclerosis in the thoracic aorta (Figure 6F),
whereas no difference was found in the abdominal aorta (Figures
6G). Analysis of cross-sections of the aortic sinus revealed no
difference between the two groups of mice in the abundance
of macrophages in the plaque and expression of VCAM-1 on
the surface of endothelium (Figures 6I and 6J). We found no dif-
ference in the abundances of collagen (Figure 6K), a marker of
protein oxidation, nitrotyrosine (Figure 6L), or in the size of the
necrotic core (Figure 6M).
Blood cell counts in the two groups ofmice after 16weeks on a
high-fat diet revealed two statistically significant differences:
in Apoe/ Abca12El12/El12 mice, the percentages of leukocytes
were lower (6.3 ± 0.5 versus 12.1% ± 1.0%; p < 0.002), and
the percent of mononuclear cells was higher (81.4% ± 1.9%
versus 69.9% ± 1.4%; p < 0.01). Plasma triglycerides, total,
non-HDL, and HDL cholesterol levels in mice transplanted with
Apoe/ Abca12+/+ or Apoe/ Abca12El12/El12 FLCs were
similar (Table S3), indicating that the enhanced atherosclerosis
was not the result of changes in plasma lipid profile.
These results indicate that Abca12 deficiency inhibits RCT
in vivo and causes the accumulation of cholesterol in macro-
phages, promoting their transformation into foam cells and
contributing to the development of atherosclerosis.
DISCUSSION
ABCA12 is a full-length ubiquitously expressed ABC trans-
porter. In the skin, ABCA12 is responsible for the transport ofbca12 knockdown. The top panels show cross-sectional images derived from
s at different depths. The bottom panel shows florescence intensity measured
s overexpressing heterologous Abca12. The scale bar represents 10 mm.
h or without Abca12 knockdown. Proteins were pulse-labeled with 35S-labeled
. Autoradiography of the Abca1 bands (M) and quantitation of the radioactivity in
ells with or without Abca12 knockdown.
h TO-901317 andwith or without Abca12 knockdown. Graph shows PLA values
nockdown. Quantitation of PLA assay (right panels in O–Q) is described in the
.01(versus control); #p < 0.01(versus nonactivated cells).
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Figure 4. Mechanism of Modulation of Cholesterol Efflux by ABCA12: Studies on HeLa-ABCA1 Cells
(A) Abundance of ABCA12 and ABCA1 in HeLa-ABCA1 cells after transient transfection with ABCA12.
(B) Cholesterol efflux to apoA-I after the overexpression of ABCA12. *p < 0.05 (versus untransfected cells).
(C and D) Intracellular distribution of ABCA1 in HeLa-ABCA1 cells transfected with or without ABCA12.
(E) Intracellular distribution of ABCA12 in HeLa-ABCA1 cells transfected with ABCA12.
(F) A merger of (D) and (E).
(G) The time course of degradation of biotinylated surface Abca1 in HeLa/ABCA1 cells with or without the overexpression of ABCA12.
(H) Quantitation of the bands in three experiments similar to that shown in (G). Means ± SEM are shown. *p < 0.01 (versus time zero).
(legend continued on next page)
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Figure 5. Lipid Accumulation in Abca12-
Deficient Cells
(A) Cholesteryl ester biosynthesis in liver macro-
phages isolated from the Abca12El12/El12 strain
with or without loading the cells with acLDL.
(B) Cholesteryl ester biosynthesis in RAW 264.7
cells after knockdown of Abca12 with siRNA with
or without loading the cells with acLDL.
(C) Oil Red O staining of RAW 264.7 cells after
knockdown of Abca12 with siRNA.
(D) Quantitation of Oil RedO staining of RAW264.7
after knockdown of Abca12 with siRNA (percent-
age of stained cells, n = 5). Pooled data are rep-
resented as the mean ± SEM. *p < 0.01 (versusWT
or control cells).
(E) Abundance of the individual lipid species in
control versus Abca12 knockdown RAW 264.7
cells after activation with LXR agonist TO-901317
with or without loading with acLDL. *p < 0.001
(versus acLDL-loaded control cells); #p < 0.01
versus non-acLDL-loaded control cells.
See also Table S2.
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ABCA12: A Regulator of Cholesterol Effluxceramides, and its mutation leads to defects in skin barrier func-
tion, leading to dehydration (Kelsell et al., 2005). Recently, our
group (Smyth et al., 2008) and others (Yanagi et al., 2008; Zuo
et al., 2008) have described mouse models of HI caused by
mutations in Abca12. These mice are not viable and die shortly
after birth. Using embryonic fibroblasts, we have demonstrated
that Abca12/ cells have severe defects in cholesterol efflux
and exceptional susceptibility to lipid overloading (Smyth et al.,
2008). These findings suggested that the physiological role of(I) Western blot after the immunoprecipitation of ABCA1 with an antibody against ABCA1 and developing w
(J) Western blot after the immunoprecipitation of ABCA12 with an antibody against tGFP and developing wi
(K) Western blot after the immunoprecipitation of LXRb and developing with antibodies against ABCA1 (top rig
or LXRb (bottom half). No primary antibody was added to the immunoprecipitation of the sample in the mid
ABCA12.
(L) PLA of the Abca1 and Abca12 pair in HeLa-ABCA1 cells transfected with or without ABCA12.
(M) PLA of the Abca1 and Lxrb pair in HeLa-ABCA1 cells transfected with or without ABCA12. Means ±
panels. *p < 0.01.
Cell Metabolism 18, 225–23ABCA12 may not be limited to skin and
may be an element of a pathway regu-
lating lipid metabolism in various tissues,
including macrophages, cells central to
the development of atherosclerosis.
The main finding of this study is that
ABCA12 is essential for the regulation of
cellular cholesterol homeostasis. A loss
of Abca12 renders macrophages unre-
sponsive to stimulation by LXR agonists,
reducing the abundance of cholesterol
transporters and the rate of cholesterol
efflux. These changes cause the accumu-
lation of cholesterol in macrophages,
their transformation into foam cells, and
the development of atherosclerosis. In
addition, Abca12 deficiency caused a
reduction in the abundance of LXRb;
reconstitution experiments employingheterologous Lxrb suggest that LXRb plays a key role in medi-
ating the effects of a loss of ABCA12. LXRs are nuclear receptors
which control the transcription of genes (Calkin and Tontonoz,
2010; Zelcer and Tontonoz, 2006); however, our findings support
a posttranscriptional model of LXRb action. It has been pro-
posed that LXRb binds to ABCA1, preventing ATP hydrolysis,
and the interaction of ABCA1 with apoA-I; LXR agonists inter-
fere with this interaction (Hozoji-Inada et al., 2011). Our studies
have established an interaction between ABCA12, ABCA1, andith an antibody against ABCA12.
th an antibody against ABCA1.
ht quarter), tGFP (an ABCA12 tag; top left quarter),
dle lane. HeLa-ABCA1 cells were transfected with
SEM of PLA signal per cell are shown in the right
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Figure 7. A Proposed Mechanism for Regu-
lating ABCA1 via ABCA12 and LXRb
‘‘Inactive’’ ABCA1 exists as a complex with
ABCA12 and LXRb. The addition of an LXR agonist
leads to the dissociation of LXR from ABCA1-
ABCA12 and the activation of ABCA1, enabling it
to hydrolyse ATP, bind apoA-I, and remain on the
cell surface, where it is stable. In the absence of
ABCA12, LXRb binds more firmly to ABCA1, and
this association is not broken by LXR agonist;
consequently, ABCA1 remains inactive and un-
stable. Overexpression of LXRb leads to the
excess of LXRb and formation of LXRb dimers in
the presence of an agonist, and these dimers
dissociate from ABCA1.
Cell Metabolism
ABCA12: A Regulator of Cholesterol EffluxLXRb that is required for ABCA1 localization to the cell surface
and is necessary for its normal activity and stability. We propose
(Figure 7) that, in the presence of LXR agonist, the ABCA1-
ABCA12-LXRb complex dissociates, leading to a stimulation of
cholesterol efflux, as suggested by Hozoji-Inada et al. (2011).
In the absence of ABCA12, LXRb binds more firmly to ABCA1,Figure 6. The Effect of Abca12 Knockout on Reverse Cholesterol Transport and Development
(A–C) The appearance of [3H]cholesterol in plasma (A), liver (B), and feces (C) 24 hr after transplanting cholest
transfected with either siRNAc (n = 6) or siRNAAbca12 (n = 5).
(D–G) Two groups of Apoe knockout mice were transplanted with either Abca12 El12/El12 (n = 10) or WT (n = 13)
for 16 weeks. Lipid accumulation and distribution and the size (area) of atherosclerotic lesions in aorta were
staining with Sudan IV. Data are represented as individual values, and the horizontal dash represents the m
(H) Representative photographs of aortas after staining with Sudan IV.
(I) Analysis of macrophage infiltration within the aortic sinus region after staining with anti-CD68.
(J) Analysis of the abundance of VCAM-1 in sections from the aortic sinus region.
(K) Analysis of the abundance of collagen in sections from the aortic sinus region.
(L) Analysis of the abundance of nitrotyrosine (NT) in sections from the aortic sinus region.
(M) Analysis of the size of the necrotic core in sections from the aortic sinus region.
(I–M) The percentage of staining in the plaque is shown. The mean ± SEM of n = 6 in each group are shown
See also Table S3.
Cell Metabolism 18, 225–23and the complex may be mislocalized;
as a result, the LXR agonist is unable
to induce dissociation. Consequently,
ABCA1 remains dysfunctional and unable
to bind apoA-I, leading to its internaliza-
tion and degradation along with LXRb.
Overexpression of LXRb favors the for-
mation of LXRb dimers, which bind more
weakly to ABCA1, allowing agonists to
disrupt the complex. Indirect evidence
in support of this hypothesis include:
(1) the binding of ABCA1 to ABCA12
and LXRb, (2) partial colocalization of
ABCA12 and ABCA1, (3) increased coloc-
alization and interaction between LXRb
and ABCA1 after the silencing of
ABCA12, (4) the ability of heterologous
ABCA12 to cause a relocalization of
ABCA1 and LXRb similar to that observed
by Hozoji-Inada et al. (2011), and (5)
the complementary effects of ABCA12
deficiency and ABCA12 overexpression
on ABCA1 stability and localization. Onthe other hand, when cells were activated with cAMP, ABCA12
deficiency did not affect ABCA1 abundance but still partially
reduced cholesterol efflux in the absence of LXR agonist.
Furthermore, ABCA12 deficiency only partially reduced ABCA1
abundance but completely blocked LXR-dependent elevation
of cholesterol efflux. Altogether, this suggests that there mayof Atherosclerosis in Vivo
erol-loaded and -labeled RAW 264.7 macrophages
bone marrow. Animals were kept on a high-fat diet
quantitatively assessed with en face analysis after
ean ± SEM. *p < 0.002.
.
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ABCA12: A Regulator of Cholesterol Effluxbe additional mechanisms underpinning the effects of ABCA12
deficiency on ABCA1 functionality. The only published mecha-
nism that might explain the effects of cAMP on ABCA1 function-
ality is via the phosphorylation of ABCA1 (Haidar et al., 2002),
which may be affected by the disruption of the ABCA1-
ABCA12 complex. Although the lack of direct evidence support-
ing this hypothesis means that we cannot definitively exclude an
unrelated mechanism, such as LXR-dependent ubiquitination
(Zelcer et al., 2009), we consider this the most likely mode of
action of ABCA12. It is important to recognize that the proposed
mechanism of the effect of ABCA12 deficiency on ABCA1
cannot be a priori extended to ABCG1. Moreover, the effects
of ABCA12 deficiency on ABCG1 may have contributed to the
reduced reverse cholesterol transport and the development
atherosclerosis in animal experiments.
Impairment of cholesterol homeostasis plays a central role
in cardiovascular, neurodegenerative, skin, and many other
disorders. The current dogma suggests that the main players
in regulating cholesterol homeostasis are the sterol regulatory
element-binding protein (SREBP)-dependent pathways (which
regulate the delivery of cholesterol to cells) and the LXR-depen-
dent pathways (which regulate the removal of cholesterol from
cells). In this study, we have identified ABCA12 as an important
player in the ‘‘removal’’ arm of cholesterol homeostasis. We
show that ABCA12 plays a key role in the posttranscriptional
regulation of cholesterol transporter ABCA1 in vitro and demon-
strate a pivotal role for ABCA12 deficiency in the development
of atherosclerosis. Our findings also suggest that ABCA12
defines a part of a pathway involved in regulation of cholesterol
homeostasis and a potential contributor to the development of
atherosclerosis.
EXPERIMENTAL PROCEDURES
Cells
The Abca12El12 and Abca12Lx12 mouse strains were described previously
(Smyth et al., 2008; Yanagi et al., 2010). Abca12El12 mice were backcrossed
for ten generations, and the mutation wasmapped to a narrow 4.7 Mb interval.
In this interval, only the Abca12 gene was found to be altered. The uterus was
removed on embryonic day (E) 12.5 of pregnancy, and embryos were isolated
under aseptic condition. The embryonic liver was dissected and cells were
suspended and cultured in a six-well tissue culture plate in Roswell Park
Memorial Institute (RPMI)-1640 medium containing 10% fetal bovine serum
and 20% L929-cell-conditioned medium as a source of colony-stimulating
factors as described by Feng et al. (2005). After 24 hr depletion of adherent
cells and debris, nonadherent macrophages were moved to fresh Petri dishes
and grown to confluence. Embryos were genotyped, and cultured macro-
phages were characterized morphologically as described by Suzuki et al.
(2000); 95% of cells were deemed to be macrophages.
RAW 264.7 cells were maintained as described previously (Mukhamedova
et al., 2008). HeLa-ABCA1 cells stably expressing GFP-tagged ABCA1 were
a kind gift of A. Remaley and were described previously (Mukhamedova
et al., 2007).
Transfections
RAW 264.7 mouse macrophages were transfected with Abca12-specific
siRNA or scrambled siRNA (control) and treated with TO-901317 (4 mM) for
18 hr. Transfection was performed with Lipofectamine RNAiMAX (Invitrogen)
following the manufacturer’s protocol. Abca12 siRNA and scrambled siRNA
were from Santa Cruz Biotechnology.
Lxrb and murine Abca12 genes were inserted into pCMV6-AC-GFP
plasmid (Origene). Human ABCA12 plasmid was a kind gift of D. Kelsell. Trans-
fections with Lxrb plasmid were performed as described previously (Escher236 Cell Metabolism 18, 225–238, August 6, 2013 ª2013 Elsevier Incet al., 2005). Transfection of HeLa cells with ABCA12 plasmid was conducted
as described previously (Mukhamedova et al., 2007).
HDL and Apolipoprotein A-I
HDL (1.083 < d < 1.21 g/L) was isolated by sequential centrifugation in KBr
solutions and delipidated, and apoA-I was purified by gel filtration chromatog-
raphy as described previously (Brace et al., 2010).
Cholesterol Efflux
Cholesterol efflux was measured as described previously (Mukhamedova
et al., 2008). In brief, cells were incubated in serum-containingmedium supple-
mented with 3H-labeled cholesterol (75 kBq/ml) for 48 hr. Then, cells were
washed with PBS and incubated for 18 hr in serum-free medium in the pres-
ence or absence of LXR agonist TO-901317 (final concentration, 4 mM).
Then, ApoA-I or isolated HDL were added to the final concentration of
30 mg/ml, and cells were incubated for 2 hr at 37C. The efflux was calculated
as a proportion of radioactivity moved from cells to medium (minus efflux to a
medium without acceptors). ABC-dependent efflux was defined as the differ-
ence in the efflux to apoA-I or HDL from cells activated with or without LXR
agonist.
Western Blot Analysis
The antibodies against ABCA1, ABCG1, SR-B1, LXRa, LXRb, and GAPDH
were from Abcam and Aviva Systems Biology. Semiquantitative analysis of
western blots was performed by densitometry and presented as a proportion
of control after normalization to loading control.
For Abca12 analysis, cellular proteins were biotinylated with 2 mM EZ-Link
NHS-LC-Biotin (Thermo Scientific) at room temperature for 1 hr. Then, cells
were lysed with NP-40 lysis buffer, and 200 mg of each the lysates was incu-
bated with 2.5 mg anti-goat ABCA12 antibody (Novus). A complex of Abca12
protein and an antibody against Abca12 was immunoprecipitated with
Sepharose-protein G beads. The protein equivalent of 100 mg of original pro-
tein lysate was run on the SDS-PAGE, and western blot was performed and
detected with horseradish-peroxidase-conjugated streptavidin.
Immunoprecipitation
Equal amounts (150 mg) of total cell lysates were used to immunoprecipitate
ABCA1, LXRb, and ABCA12-turboGFP proteins. In brief, radio-immunoprecip-
itation assay (RIPA) lysates were incubated with 2 mg of rabbit polyclonal
ABCA1 (Novus), turboGFP (Evrogen), or LXRb (Abcam) antibody overnight at
4C. Protein A-Sepharose beads (Thermo Scientific) were added to the anti-
body and protein mixture. After incubation for 3 hr with rotating at 4C, beads
were washed with PBS.
Pulse-Chase Experiments
RAW 264.7 cells were transfected with Abca12-siRNA or scrambled siRNA as
described above. After 48 hr posttransfection, the cells were activated with
4 mM TO-901317 for 3 hr in culture medium and then incubated in methionine-
and cysteine-free RPMI (Sigma-Aldrich) with TO-901317 for 1 hr. The cells
were pulsed with 100 mCi/ml of 35S-labeled methionine and cysteine
(PerkinElmer, EasyTag EXPRESS Protein Labeling Mix) for 2 hr, washed in
PBS, and chased in RPMImedium supplementedwith 1.5mg/ml L-methionine
and 0.5 mg/ml L-cysteine (Sigma-Aldrich) for the indicated times. ABCA1
protein was determined by immunoprecipitation with an affinity-purified anti-
rabbit ABCA1 antibody, separated by SDS-PAGE, transferred to polyvinyli-
dene difluoride membrane, and exposed to autoradiography film.
Biotinylation of Cell-Surface Proteins
Cells were washed three times with ice cold PBS and biotinylated with Sulfo-
NHS-SS-Biotin as described previously (Cui et al., 2012). After biotinylation,
cells were washed twice with 50 mM Tris and 150 mM NaCl to quench the re-
action andoncewithPBS.After incubation in serum-freeRPMImediumat 37C
for 0, 4, or 24 hr, cells were lysed with RIPA buffer. Biotinylated proteins were
purified with UltraLink Plus immobilized streptavidin gel (Thermo Scientific).
Cholesteryl Ester Biosynthesis
Cells were incubated for 18 hr in serum-containing medium in the presence or
absence of 50 mg/ml of acetylated LDL. Then, cholesteryl ester biosynthesis.
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as described previously (Mujawar et al., 2006). The staining of cells with Oil
Red O was performed as described previously (Smyth et al., 2008).
Real-Time RT-PCR
PCR primers were obtained from TaqMan Gene Expression Assays with
the following gene assay IDs: Mm00442646_m1, Mm00550501_m1,
Mm00613683_m1, Mm00437390_m1, Mm00443451_m1, Mm00437262_m1,
Mm00450234_m1, Mm00446214_m1, Mm00440169_m1, and Mm01282499_
m1. Real-time PCR reactions were performed on a 7500 Fast System from ABI
Applied Biosystems. The relative amount of mRNA was calculated with the
comparative CT method. Gene expression was normalized to 18 s rRNA.
Lipidomics
RAW264.7 cells were transfected with siRNAAbca12 or siRNAc, activated with
4 mM TO-901317 for 24 hr, and incubated with or without 50 mg/ml acetylated
LDL overnight. Cells were washed with PBS, resuspended into 20mM Tris and
500 mM NaCl solution containing 0.1 mM butylated hydroxytoluene, and
sonicated. Ten microliters (20 mg of protein) of each the supernatant were
subjected to lipids extraction and analysis via mass spectrometry.
Confocal Microscopy
For imaging, RAW 264.7 or HeLa-ABCA1 cells were grown in a Lab-Tek II
Chamber Slide System (Thermo Scientific). In HeLa-ABCA1 cells, ABCA1
was fused with GFP; in RAW 264.7 cells, it was stained with monoclonal
antibody against ABCA1 (Abcam) and AlexaFluor 488 anti-mouse IgG second-
ary antibody (Invitrogen). Lxrb was stained with polyclonal primary antibody
(Abcam) and AlexaFluor 633 anti-rabbit secondary antibody (Invitrogen).
Abca12 staining in RAW 264.7 cells was performed with in-house antibodies
against Abca12 and AlexaFluor 488 anti-mouse IgG secondary antibody and
in HeLa-ABCA1 cells with an antibody against ABCA12 (Novus) and Texas
Red 633 anti-rabbit secondary antibody. Colocalization was quantitated
with Zeiss LSM Image Browser as described previously (Zinchuk and
Grossenbacher-Zinchuk, 2011; Zinchuk et al., 2007) and expressed as an
unweighted colocalization coefficient of Lxrb with Abca1on full images (ten
images, six to eight cells per image, and three experiments).
In Situ Proximity Ligation Assay
The general principle of the Duolink in situ coimmunoprecipitation assay
has been described previously (Baima et al., 2010). Cells were seeded at
1 3 104 cells per well on eight-well Lab-Tek II Chamber Slides and incubated
to 80% confluence. After 48 hr posttransfection, cells were washed with
PBS, fixed in 4% paraformaldehyde for 15 min, and permeabilized in
0.01% Triton X-100 for 10 min. Nonspecific binding was blocked by incu-
bating cells for 30 min at 37C with a blocking solution provided by the
manufacturer. The cells were incubated overnight at 4C with two antibodies
raised in different species. The proximity ligation assay was conducted with a
Duolink Orange Detection kit. Images were quantified by counting total
number of PLA signals in each image and dividing by the number of nuclei
in the field of view. Counting was conducted with ImageJ in automatic
mode. A total of several hundred individual cells were counted for each
group of samples.
In Vivo Reverse Cholesterol Transport Assay
Cholesterol efflux in vivo was measured with the use of a model described by
Wang et al. (2007) with previously described modifications (Mukhamedova
et al., 2008).
Bone Marrow Transplantation
After backcrossing ten generations to C57BL/6, the Abca12El12 mutation was
backcrossed onto a C57BL/6 Apoe-deficient background. Then, C57BL/6
CD45.2 Abca12-/+ Apoe/ mice were intercrossed, and E13.5 livers were
harvested from embryos. Two million fetal liver cells were transplanted into
adult C57BL/6 CD45.1 Apoe/ recipients in whom endogenous hematopoie-
sis had been ablated by irradiation (11 Gy in 2 equal doses 2–3 hr apart). After
8 weeks posttransplantation, donor engraftment was determined by flow
cytometric analysis of peripheral blood leukocyte in conjunction with CD45-
specificmonoclonal antibody. Then, 8 weeks postreconstitution, bonemarrowCelchimera mice were put on a high-fat diet (21% fat, 0.15% cholesterol) for
16 weeks. Lipid accumulation and distribution and size (area) of atheroscle-
rotic lesions in aorta were quantitatively assessedwith an en face analysis after
being stained with Sudan IV.
Heart tissue containing the aortic sinus was embedded in optimum
cutting temperature compound (Tissue-Tek) and frozen in order to assess
plaques within the aortic sinus region. Consecutive 10 mm sections span-
ning 240 mm of the aortic sinus were cut and collected. Sections were
stained with Masson’s trichrome stain in order to detect collagen. Sections
were also examined for macrophage content as well as inflammatory
and oxidation markers by immunohistochemistry with the following pri-
mary antibodies: anti-CD68 (AbD, Serotec), anti-VCAM-1 (BD Pharmingen),
and anti-Nitrotyrosine (Millipore). Images were quantified with Image-Pro
Plus 6.0.
All animal experiments complied with the regulatory standards of and were
approved by the Walter and Eliza Hall Institute Animal Ethics Committee and/
or the Alfred Medical Research and Education Precinct Animal Ethics
Committee.
Statistics
All in vitro experiments were performed in quadruplicates and repeated two to
three times. Statistical analysis was performed with Student’s t tests and one-
way ANOVA modified by a step-down Bonferroni procedure, and both tests
produced identical results. Means ± SEM are shown.
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